Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Etude comparative And NotJoanne Wojcieszek

List of bibliographic references

Number of relevant bibliographic references: 204.
Ident.Authors (with country if any)Title
000119 Claire Hinnell [Royaume-Uni] ; Catherine S. Hurt [Royaume-Uni] ; Sabine Landau [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Michael Samuel [Royaume-Uni]Nonmotor Versus Motor Symptoms: How Much Do They Matter to Health Status in Parkinson's Disease?
000233 Esther Cubo [Espagne] ; Jose M. Trejo Gabriel-Galan [Espagne] ; Joaquin Seco Martinez [Espagne] ; Carlos Rioja Alcubilla [Espagne] ; CHENGWU YANG [États-Unis] ; Olga Fernandez Arconada [Espagne] ; Natividad Mariscal Perez [Espagne]Comparison of Office-Based Versus Home Web-Based Clinical Assessments for Parkinson's Disease
000234 Scott Y. H. Kim [États-Unis] ; Renee M. Wilson [États-Unis] ; H. Myra Kim [États-Unis] ; Robert G. Holloway [États-Unis] ; Raymond G. De Vries [États-Unis] ; Samuel A. Frank [États-Unis] ; Karl Kieburtz [États-Unis]Comparison of Enrollees and Decliners of Parkinson Disease Sham Surgery Trials
000235 Alice K. Silbergleit [États-Unis] ; Peter Lewitt [États-Unis] ; Fred Junn [États-Unis] ; Lonni R. Schultz [États-Unis] ; Denise Collins [États-Unis] ; Tausha Beardsley [États-Unis] ; Meghan Hubert [États-Unis] ; Richard Trosch [États-Unis] ; Jason M. Schwalb [États-Unis]Comparison of Dysphagia Before and After Deep Brain Stimulation in Parkinson's Disease
000283 Elan D. Louis [États-Unis] ; Edward D. Huey [États-Unis] ; Marina Gerbin [États-Unis] ; Amanda S. Viner [États-Unis]Apathy in Essential Tremor, Dystonia, and Parkinson's Disease: A Comparison with Normal Controls
000325 Kotaro Ogaki [Japon] ; Yumiko Motoi [Japon] ; YUANZHE LI [Japon] ; Hiroyuki Tomiyama [Japon] ; Natsue Shimizu [Japon] ; Masashi Takanashi [Japon] ; Atsushi Nakanishi [Japon] ; Kazumasa Yokoyama [Japon] ; Nobutaka HattoriVisual Grasping in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (Microtubule-Associated with Protein Tau): A Comparison of N-Isopropyl-p-[123I]-iodoamphetamine Brain Perfusion Single Photon Emission Computed Tomography Analysis with Progressive Supranuclear Palsy
000365 Dustin A. Heldman [États-Unis] ; Joseph P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Alberto J. Espay [États-Unis]The Modified Bradykinesia Rating Scale for Parkinson's Disease: Reliability and Comparison with Kinematic Measures
000446 Mauro Manconi [Italie, Suisse] ; Raffaele Ferri [Italie] ; Marco Zucconi [Italie] ; Alessandro Oldani [Italie] ; Laura Giarolli [Italie] ; Valentina Bottasini [Italie] ; Luigi Ferini-Strambi [Italie]Pramipexole Versus Ropinirole: Polysomnographic Acute Effects in Restless Legs Syndrome
000473 Fabrizio Stocchi [Italie] ; Luiqi Giorqi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni]PREPARED: Comparison of Prolonged and Immediate Release Ropinirole in Advanced Parkinson's Disease
000571 Alessandro Picelli [Italie] ; Nicola Smania [Italie] ; Ilaria Storti [Italie] ; Daniele Munari [Italie] ; Carla Fontana [Italie] ; Antonio Fiaschi [Italie] ; Valter Santilli [Italie] ; Stefano Tamburin [Italie]Immediate Versus Delayed Electrical Stimulation Boosts Botulinum Toxin Effect: A Pilot Study
000592 Omar S. Mian [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] ; Brian L. Day [Royaume-Uni]Gait in SWEDDs Patients: Comparison with Parkinson's Disease Patients and Healthy Controls
000649 Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Ann Hsu [États-Unis] ; Martin J. O'Connell [États-Unis] ; Nishit B. Modi [États-Unis] ; Hsuan-Ming Yao [États-Unis] ; Sherron H. Kell [États-Unis] ; Suneel K. Gupta [États-Unis]Crossover Comparison of IPX066 and a Standard Levodopa Formulation in Advanced Parkinson's Disease
000657 Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie]Comparison of Subthalamic Nucleus Deep Brain Stimulation and Duodopa in the Treatment of Advanced Parkinson's Disease
000658 Yi-Chung Lee [Taïwan] ; Yi-Chu Liao [Taïwan] ; Po-Shan Wang [Taïwan] ; I-Hui Lee [Taïwan] ; Kon-Ping Lin [Taïwan] ; Bing-Wen Soong [Taïwan]Comparison of Cerebellar Ataxias: A Three-Year Prospective Longitudinal Assessment
000692 Arianna Guidubaldi [Italie] ; Alfonso Fasano [Italie] ; Tamara Lalongo [Italie] ; Carla Piano [Italie] ; Maurizio Pompili [Italie] ; Roberta Masciana [Italie] ; Luisa Siciliani [Italie] ; Mario Sabatelli [Italie] ; Anna Rita Bentivoglio [Italie]Botulinum Toxin A Versus B in Sialorrhea: A Prospective, Randomized, Double-Blind, Crossover Pilot Study in Patients with Amyotrophic Lateral Sclerosis or Parkinson's Disease
000730 Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis]A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease
000932 Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Koichi Hirata [Japon]Olfactory Dysfunction in Japanese Patients with Idiopathic REM Sleep Behavior Disorder: Comparison of Data Using the University of Pennsylvania Smell Identification Test and Odor Stick Identification Test for Japanese
000A07 Charles H. Adler [États-Unis] ; Donald J. Connor [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; John N. Caviness [États-Unis] ; Holly A. Shill [États-Unis] ; Brie Noble [États-Unis] ; Thomas G. Beach [États-Unis]Incidental Lewy Body Disease: Clinical Comparison to a Control Cohort
000A90 Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis]Early Versus Delayed Bilateral Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Decision Analysis
000B04 Julie H. Carter [États-Unis] ; Karen S. Lyons [États-Unis] ; Barbara J. Stewart [États-Unis] ; Patricia G. Archbold [États-Unis] ; Rebecca Scobee [États-Unis]Does Age Make a Difference in Caregiver Strain? Comparison of Young Versus Older Caregivers in Early-Stage Parkinson's Disease
000B40 William G. Ondo [États-Unis] ; Lina Shinawi [États-Unis] ; Steven Moore [États-Unis]Comparison of Orally Dissolving Carbidopa/Levodopa (Parcopa) to Conventional Oral Carbidopa/Levodopa: A Single-Dose, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Trial
000C13 Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
000C42 Laura Mickes [États-Unis] ; Mark Jacobson [États-Unis] ; Guerry Peavy [États-Unis] ; John T. Wixted [États-Unis] ; Stephanie Lessig [États-Unis] ; Jody L. Goldstein [États-Unis] ; Jody Corey-Bloom [États-Unis]A Comparison of Two Brief Screening Measures of Cognitive Impairment in Huntington's Disease
000C43 Ji E. Lee [Corée du Sud] ; Bosuk Park [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]A Comparison of Gray and White Matter Density in Patients with Parkinson's Disease Dementia and Dementia with Lewy Bodies Using Voxel-Based Morphometry
000C44 Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Bum [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]A Comparison of Depression, Anxiety, and Health Status in Patients with Progressive Supranuclear Palsy and Multiple System Atrophy
000D25 Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie]Rehabilitation Treatment of Gait in Patients with Parkinson's Disease with Freezing: A Comparison Between Two Physical Therapy Protocols Using Visual and Auditory Cues with or Without Treadmill Training
000D54 Peter A. Lewitt [États-Unis] ; Danna Jennings [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Adrian L. Rabinowicz [États-Unis] ; James Wang [États-Unis] ; Maria Guamieri [États-Unis] ; Jean P. Hubble [États-Unis] ; Harold Murck [États-Unis]Pharmacokinetic-Pharmacodynamic Crossover Comparison of Two Levodopa Extension Strategies
000E36 Jan Herzog [Allemagne] ; Bettina Möller [Allemagne] ; Karsten Witt [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne]Influence of Subthalamic Deep Brain Stimulation Versus Levodopa on Motor Perseverations in Parkinson's Disease
000F04 Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
000F13 Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Carmine Mollica [Italie] ; Elena Salvatore [Italie] ; Marta Ianniciello [Italie] ; Katia Longo [Italie] ; Andrea Varrone [Italie] ; Caterina Vicidomini [Italie] ; Marina Picillo [Italie] ; Giuseppe De Michele [Italie] ; Alessandro Filla [Italie] ; Marco Salvatore [Italie] ; Sabina Pappata [Italie]Diffusion-Weighted Imaging in Multiple System Atrophy : A Comparison Between Clinical Subtypes
000F35 Paul Sauleau [France] ; Emmanuelte Leray [France] ; Tiphaine Rouaud [France] ; Sophie Drapier [France] ; Dominique Drapier [France] ; Sophie Blanchard [France] ; Gwenolla Drillet [France] ; Julie Peron [France] ; Marc Verin [France]Comparison of Weight Gain and Energy Intake After Subthalamic Versus Pallidal Stimulation in Parkinson's Disease
000F36 Katrin Bürk [Allemagne] ; Ulrike M Lzig [Allemagne] ; Stefanie Wolf [Allemagne] ; Suzette Heck [Allemagne] ; Konstantinos Dimitriadis [Allemagne] ; Tanja Sehmitz-Hübseh [Allemagne] ; Sascha Hering [Autriche] ; Tobias M. Lindig [Allemagne] ; Verena Haug [Allemagne] ; Dagmar Timmann [Allemagne] ; Ingrid Degen [Allemagne] ; Bernd Kruse [Allemagne] ; Jan-Markus Dörr [Allemagne] ; Susanne Ratzka [Allemagne] ; Anja Ivo [Allemagne] ; Ludger Schöls [Allemagne] ; Sylvia Boesch [Autriche] ; Thomas Klockgether [Allemagne] ; Thomas Klopstock [Allemagne] ; Jörg B. Schulz [Allemagne]Comparison of Three Clinical Rating Scales In Friedreich Ataxia (FRDA)
001008 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A Comparison of Treatment Thresholds in Two Large Parkinson's Disease Clinical Trial Cohorts
001038 Uwe Walter [Allemagne] ; Dirk Dressier [Allemagne] ; Christian Lindemann [Chili] ; Andrea Slachevsky [Chili] ; Marcelo Miranda [Chili]Transcranial Sonography Findings in Welding-Related Parkinsonism in Comparison to Parkinson's Disease
001101 Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Teus Van Laar [Pays-Bas] ; Chuanchieh Hsu [États-Unis] ; Wemer Poewe [Autriche] ; Roger M. Lane [États-Unis]Rivastigmine Versus Placebo in Hyperhomocysteinemic Parkinson's Disease Dementia Patients
001136 Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Charles H. Adler [États-Unis] ; Stanley Fahn [États-Unis] ; Curt R. Freed [États-Unis] ; Robert A. Hauser [États-Unis] ; Warren C. Olanow [États-Unis] ; Ira Shoulson [États-Unis] ; P. K. Tandon [États-Unis] ; Sue Leurgans [États-Unis]Placebo Response in Parkinson's Disease : Comparisons Among 11 Trials Covering Medical and Surgical Interventions
001155 Pierre J. Blanchet [Canada] ; Romana Popovici [Canada] ; Francine Guitard [Canada] ; Pierre H. Rompre [Canada] ; Claude Lamarche [Canada] ; Gilles J. Lavigne [Canada]Pain and Denture Condition in Edentulous Orodyskinesia : Comparisons with Tardive Dyskinesia and Control Subjects
001205 P. Richard Schuurman [Pays-Bas] ; D. Andries Bosch [Pays-Bas] ; Maruschka P. Merkus [Pays-Bas] ; Johannes D. Speelman [Pays-Bas]Long-Term Follow-Up of Thalamic Stimulation Versus Thalamotomy for Tremor Suppression
001315 Esther Cubo [États-Unis, Espagne] ; Teresa Chmura [États-Unis] ; Christopher G. Goetz [États-Unis]Comparison of Tic Characteristics Between Children and Adults
001316 David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France]Comparison of Desipramine and Citalopram Treatments for Depression in Parkinson's Disease : A Double-Blind, Randomized, Placebo-Controlled Study
001317 Kimiyoshi Arimura [Japon] ; Yumiko Arimura [Japon] ; Yoshiharu Takata [Japon] ; Tomonori Nakamura [Japon] ; Ryuji Kaji [Japon]Comparative Electrophysiological Study of Response to Botulinum Toxin Type B in Japanese and Caucasians
001394 Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada]A Comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identifying Cognitive Deficits in Parkinson's Disease
001395 Haruko Tanji [États-Unis] ; Ann L. Gruber-Baldini [États-Unis] ; Karen E. Anderson [États-Unis] ; Ingrid Pretzer-Aboff [États-Unis] ; Stephen G. Reich [États-Unis] ; Paul S. Fishman [États-Unis] ; William J. Weiner [États-Unis] ; Lisa M. Shulman [États-Unis]A Comparative Study of Physical Performance Measures in Parkinson's Disease
001396 Sanne Boesveldt [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Dirk L. Knol [Pays-Bas] ; Martine Visser [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Henk W. Berendse [Pays-Bas]A Comparative Study of Odor Identification and Odor Discrimination Deficits in Parkinson's Disease
001415 Asha Kishore [Canada] ; Alberto J. Espay [Canada] ; Connie Marras [Canada] ; Thamer Al-Khairalla [Canada] ; Tamara Arenovich [Canada] ; Abena Asante [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada]Unilateral versus bilateral tasks in early asymmetric Parkinson's disease : Differential effects on bradykinesia
001426 Anelyssa D'Abreu [Brésil] ; Marcondes Jr Franca [Brésil] ; Iscia Lopes-Cendes [Brésil] ; Fernando Cendes [Brésil]The international cooperative ataxia rating scale in machado-joseph disease. comparison with the unified multiple system atrophy rating scale
001443 Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni]Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
001455 Ali Samii [États-Unis] ; Valerie E. Kelly [États-Unis] ; Jefferson C. Slimp [États-Unis] ; Anne Shumway-Cook [États-Unis] ; Robert Goodkin [États-Unis]Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease
001472 Jordan J. Elm [États-Unis] ; Cornelia Kamp [États-Unis] ; Barbara C. Tilley [États-Unis] ; Paulo Guimaraes [États-Unis] ; Debbie Fraser [États-Unis] ; Patricia Deppen [États-Unis] ; Alicia Brocht [États-Unis] ; Chris Weaver [États-Unis] ; Susan Bennett [États-Unis]Self-reported adherence versus pill count in Parkinson's disease : The NET-PD experience
001474 Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Liling Warren [États-Unis] ; Rim Amouri [Tunisie] ; Kelly Lyons [États-Unis] ; Catherine Wielinski [États-Unis] ; Christine Hunter [États-Unis] ; Jina E. Swartz [Royaume-Uni] ; Ramu Elango [Royaume-Uni] ; P. Anthony Akkari [États-Unis] ; David Leppert [Royaume-Uni] ; Linda Surh [Royaume-Uni] ; Kevin H. Reeves [États-Unis] ; Siwan Thomas [Royaume-Uni] ; Leigh Ragone [États-Unis] ; Nobutaka Hattori [Japon] ; Rajesh Pahwa [États-Unis] ; Joseph Jankovic [États-Unis] ; Martha Nance [États-Unis] ; Alan Freeman [États-Unis] ; Neziha Gouider-Khouja [Tunisie] ; Mounir Kefi [Tunisie] ; Mourad Zouari [Tunisie] ; Samia Ben Sassi [Tunisie] ; Samia Ben Yahmed [Tunisie] ; Ghada El Euch-Fayeche [Tunisie] ; Lefkos Middleton [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Ray L. Watts [États-Unis] ; Faycal Hentati [Tunisie]Screening for Lrrk2 G2019S and clinical comparison of tunisian and North American caucasian Parkinson's disease families
001477 Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]Rotigotine Transdermal Patch in Early Parkinson's Disease : A Randomized, Double-Blind, Controlled Study Versus Placebo and Ropinirole
001512 Francesc Valldeoriola [Espagne] ; Ossama Morsi [Espagne] ; Eduardo Tolosa [Espagne] ; Jordi Rumia [Espagne] ; Maria José Marti [Espagne] ; Pablo Martinez-Martin [Espagne]Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease
001641 Karen E. Anderson [États-Unis] ; Ann L. Gruber-Baldini [États-Unis] ; Christopher G. Vaughan [États-Unis] ; Stephen G. Reich [États-Unis] ; Paul S. Fishman [États-Unis] ; William J. Weiner [États-Unis] ; Lisa M. Shulman [États-Unis]Impact of Psychogenic Movement Disorders Versus Parkinson's on Disability, Quality of Life, and Psychopathology
001689 Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox [Allemagne] ; Torsten Roscher [Allemagne] ; Dieter Schremmer [Allemagne] ; Ariel Gordin [Allemagne]Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off
001711 Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Claudia Liener [Autriche] ; Sylvia Boesch [Autriche] ; Dirk Heute [Autriche] ; Katherina J. Mair [Autriche] ; Joerg Mueller [Autriche] ; Martin Sawires [Autriche] ; Christoph Scherfler [Autriche] ; Michael F. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Irene Virgolini [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Diffusion weighted imaging best discriminates PD from MSA-P : A comparison with tilt table testing and heart MIBG scintigraphy
001737 Kyum-Yil Kwon [Corée du Sud] ; Choong G. Choi [Corée du Sud] ; Jae S. Kim [Corée du Sud] ; Myoung C. Lee [Corée du Sud] ; Sun J. Chung [Corée du Sud]Comparison of Brain MRI and 18F-FDG PET in the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
001810 Katia Noyes [États-Unis] ; HANGSHENG LIU [États-Unis] ; Robert Holloway [États-Unis] ; Andrew W. Dick [États-Unis]Accuracy of medicare claims data in identifying parkinsonism cases : Comparison with the medicare current beneficiary survey
001829 Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni]A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
001887 Lisa M. Shulman [États-Unis] ; Ingrid Pretzer-Aboff [États-Unis] ; Karen E. Anderson [États-Unis] ; Rashida Stevenson [États-Unis] ; Christopher G. Vaughan [États-Unis] ; Ann L. Gruber-Baldini [États-Unis] ; Stephen G. Reich [États-Unis] ; William J. Weiner [États-Unis]Subjective report versus objective measurement of activities of daily living in parkinson's disease
001905 Dennis A. Nowak [Royaume-Uni, Allemagne] ; Stephen Tisch [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Helge Topka [Allemagne] ; John C. Rothwell [Royaume-Uni]Sensory timing cues improve akinesia of grasping movements in Parkinson's disease : A comparison to the effects of subthalamic nucleus stimulation
001967 Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne]Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study
001999 Alfonso Fasano [Italie] ; Nardo Nardocci [Italie] ; Antonio Emanuele Elia [Italie] ; Giovanna Zorzi [Italie] ; Anna Rita Bentivoglio [Italie] ; Alberto Albanese [Italie]Non-DYT1 early-onset primary torsion dystonia : Comparison with DYT1 phenotype and review of the literature
001A83 Pablo Martinez-Martin [Espagne] ; M. Joao Forjaz [Espagne] ; Esther Cubo [Espagne] ; Belén Frades [Espagne] ; Jesus De Pedro Cuesta [Espagne]Global versus factor-related impression of severity in Parkinson's disease : A new clinimetric index (CISI-PD)
001B09 Hiroki Fukuda [Japon] ; Masayoshi Kusumi [Japon] ; Kenji Nakashima [Japon]Epidemiology of primary focal dystonias in the western area of tottori prefecture in Japan : Comparison with prevalence evaluated in 1993
001B71 Nicholas J. Cordato [Australie] ; Glenda M. Halliday [Australie] ; Diana Caine [Australie] ; John G. L. Morris [Australie]Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease
001B74 Carmen Cristea Janvin [Norvège] ; Jan Petter Larsen [Norvège] ; David P. Salmon [États-Unis] ; Douglas Galasko [États-Unis] ; Kenneth Hugdahl [Norvège] ; Dag Aarsland [Norvège]Cognitive profiles of individual patients with Parkinson's disease and dementia : Comparison with dementia with lewy bodies and Alzheimer's disease
001B80 Liesl M. Allcock [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] ; David J. Burn [Royaume-Uni]Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension : Autonomic symptom and demographic comparison
001C84 Esther Cubo [Espagne, États-Unis] ; Vanessa K. Hinson [Espagne] ; Christopher G. Goetz [Espagne] ; Pedro Garcia Ruiz [Espagne] ; Justo Garcia De Yebenes [Espagne] ; Maria José Marti [Espagne] ; Maria Cruz Rodriguez Oroz [Espagne] ; Gurutz Linazasoro [Espagne] ; José Chacon [Espagne] ; Antonio Vazquez [Espagne] ; Javier Lopez Del Val [Espagne] ; Sue Leurgans [Espagne] ; Joanne Wuu [Espagne]Transcultural comparison of psychogenic movement disorders
001D42 Tomaso Scaravilli [Italie] ; Eduardo Tolosa [Espagne] ; Isidre Ferrer [Espagne]Progressive supranuclear palsy and corticobasal degeneration : Lumping versus splitting
001D85 Jong-Hoon Kim [Corée du Sud] ; Young-Ho Jin [Corée du Sud] ; UNG GU KANG [Corée du Sud] ; YONG MIN AHN [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; YONG SIK KIM [Corée du Sud]Neuroleptic-induced acute and chronic akathisia : A clinical comparison
001E25 Rene J. Stolwyk [Australie] ; Tom J. Triggs [Australie] ; Judith L. Charlton [Australie] ; Robert Iansek [Australie] ; John L. Bradshaw [Australie]Impact of internal versus external cueing on driving performance in people with Parkinson's disease
001E27 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment
001E78 Reinoud C. Klein [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease
001E79 Hansjorg B Zner [Allemagne] ; Jurik Schanz [Allemagne] ; Christian Blahak [Allemagne] ; Eva Grips [Allemagne] ; Johannes C. Wöhrle [Allemagne] ; Michael Hennerici [Allemagne]Differential pattern of hand-tapping compromise in vascular versus idiopathic parkinsonism : A study based on computerized movement analysis
001E90 Victor Lun [Canada] ; Nancy Pullan [Canada] ; Nancy Labelle [Canada] ; Corey Adams [Canada] ; Oksana Suchowersky [Canada]Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease
002141 Aileen K. Ho [Royaume-Uni, Australie] ; Anna O. G. Robbins [Royaume-Uni] ; Stephen J. Walters [Royaume-Uni] ; Stephen Kaptoge [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Health-related quality of life in Huntington's disease: A comparison of two generic instruments, SF-36 and SIP
002197 Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Regina Esterhammer [Autriche] ; Christian Kremser [Autriche] ; Christoph Scherfler [Autriche] ; Anja Diem [Autriche] ; Werner Jaschke [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
002198 Enrique Noe [États-Unis, Espagne] ; Karen Marder [États-Unis] ; Karen L. Bell [États-Unis] ; Diane M. Jacobs [États-Unis] ; Jennifer J. Manly [États-Unis] ; Yaakov Stern [États-Unis]Comparison of dementia with Lewy bodies to alzheimer's Disease and Parkinson's disease with dementia
002273 Anette Schrag [Royaume-Uni] ; Anna Hovris [Royaume-Uni] ; David Morley [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences
002341 Cynthia L. Comella [États-Unis] ; Sue Leurgans [États-Unis] ; Joanne Wuu [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Teresa Chmura [États-Unis]Rating scales for dystonia: A multicenter assessment
002344 Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon]Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
002390 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis]Olfaction in essential tremor patients with and without isolated rest tremor
002393 Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002413 Mona Ragothaman [Inde] ; Uday A. Murgod [Inde] ; Gopalkrishna Gururaj [Inde] ; Subbakrishna D. Kumaraswamy [Inde] ; Uday Muthane [Inde]Lower risk of Parkinson's disease in an admixed population of European and Indian origins
002424 Zelma H. T. Kiss [Canada] ; Marshall Wilkinson [Canada] ; Jerry Krcek [Canada] ; Oksana Suchowersky [Canada] ; BIN HU [Canada] ; William F. Murphy [Canada] ; Doug Hobson [Canada] ; Ron R. Tasker [Canada]Is the target for thalamic deep brain stimulation the same as for thalamotomy?
002463 Shinichi Matsumoto [Japon] ; Masataka Nishimura [Japon] ; Hiroshi Shibasaki [Japon] ; Ryuji Kaji [Japon]Epidemiology of primary dystonias in Japan: Comparison with western countries
002488 Amy J. Bastian [États-Unis] ; Valerie E. Kelly [États-Unis] ; Fredy J. Revilla [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Jonathan W. Mink [États-Unis]Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's Disease
002520 Björn Holmberg [Suède] ; Bo Johnels [Suède] ; Kaj Blennow [Suède] ; Lars Rosengren [Suède]Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
002524 Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne]Cabergoline versus levodopa monotherapy: A decision analysis
002551 Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon]0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's Disease
002584 Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis]The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia
002626 Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation
002663 Francois Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease
002665 Irene Hegeman Richard [États-Unis] ; Michelle Papka [États-Unis] ; Ana Rubio [États-Unis] ; Roger Kurlan [États-Unis]Parkinson's disease and dementia with Lewy bodies: One disease or two?
002681 Nicola Modugno [Italie] ; Yusaku Nakamura [Italie] ; Sven Bestmann [Royaume-Uni] ; Antonio Curra [Italie] ; Alfredo Berardelli [Italie] ; John Rothwell [Italie, Royaume-Uni]Neurophysiological investigations in patients with primary writing tremor
002687 Mehran Ghaemi [Allemagne] ; Jan Raethjen [Allemagne] ; Rüdiger Hilker [Allemagne] ; Jobst Rudolf [Allemagne] ; Jan Sobesky [Allemagne] ; Günther Deuschl [Allemagne] ; Wolf-Dieter Heiss [Allemagne]Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study
002731 Laura Camfield [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Impact of cervical dystonia on quality of life
002766 S. H. Subramony [États-Unis] ; Dena Hernandez [États-Unis] ; Amanda Adam [États-Unis] ; Stephanie Smith-Jefferson [États-Unis] ; Jennifer Hussey [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Timothy Lynch [États-Unis, Irlande (pays)] ; Olga Mcdaniel [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] ; Matt Farrer [États-Unis] ; Andrew Singleton [États-Unis]Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians
002847 Francesc Valldeoriola [Espagne] ; Manuela Pilleri [Espagne] ; Eduardo Tolosa [Espagne] ; José L. Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne]Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: Long-term follow-up of patients
002872 Andrea Varrone [États-Unis] ; Kenneth L. Marek [États-Unis] ; Danna Jennings [États-Unis] ; Robert B. Innis [États-Unis] ; John P. Seibyl [États-Unis][123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's Disease and multiple system atrophy
002892 Markus Kofler [Autriche] ; Jörg Müller [Espagne] ; Gregor K. Wenning [Espagne] ; Laura Reggiani [Espagne] ; Pia Hollosi [Espagne] ; Sylvia Bösch [Espagne] ; Gerhard Ransmayr [Espagne] ; Josep Valls-Sole [Autriche] ; Werner Poewe [Espagne]The auditory startle reaction in Parkinsonian disorders
002905 Virgilio G. H. Evidente [États-Unis] ; John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Katrina A. Gwinn-Hardy [États-Unis] ; Richard E. Pratley [États-Unis]Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss
002919 William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie]Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
002948 Jaime Kulisevsky [Espagne] ; Irene Litvan [États-Unis] ; Marcelo L. Berthier [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jane S. Paulsen [États-Unis] ; Jeffrey L. Cummings [États-Unis]Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders
002952 Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan
002A05 Elan D. Louis [États-Unis] ; Leon S. Iv Dure [États-Unis] ; Seth Pullman [États-Unis]Essential tremor in childhood: A series of nineteen cases
002A06 Andrea S. Winkler [Royaume-Uni] ; Joanne Marsden [Royaume-Uni] ; Matthew Parton [Royaume-Uni] ; Peter J. Watkins [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni]Erythropoietin deficiency and anaemia in multiple system atrophy
002A30 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Tröster [États-Unis] ; John Overman [États-Unis] ; Jennifer Kieltyka [États-Unis] ; William C. Koller [États-Unis]Comparison of thalamotomy to deep brain Stimulation of the thalamus in Essential tremor
002A31 Elan D. Louis [États-Unis] ; Seth L. Pullman [États-Unis]Comparison of clinical vs. electrophysiological methods of diagnosing of Essential tremor
002A58 Bradley F. Boeve [États-Unis] ; Michael H. Silber [États-Unis] ; Tanis J. Ferman [États-Unis] ; John A. Lucas [États-Unis] ; Joseph E. Parisi [États-Unis]Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy
002A77 Walter Pirker [Autriche] ; Susanne Asenbaum [Autriche] ; Gerhard Bencsits [Autriche] ; Daniela Prayer [Autriche] ; Willibald Gerschlager [Autriche] ; Lüder Deecke [Autriche] ; Thomas Brücke [Autriche][123I]β-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration
002A79 Gaetan Garraux [Belgique] ; Eric Salmon [Belgique] ; Philippe Peigneux [Belgique] ; Alexandre Kreisler [France] ; Christian Degueldre [Belgique] ; Christian Lemaire [Belgique] ; Alain Destée [France] ; Georges Franck [Belgique]Voxel-based distribution of metabolic impairment in corticobasal degeneration
002A97 Roberta Marchese [Italie] ; Manuela Diverio [Italie] ; Francesca Zucchi [Italie] ; Carmelo Lentino [Italie] ; Giovanni Abbruzzese [Italie]The role of sensory cues in the rehabilitation of parkinsonian patients : A comparison of two physical therapy protocols
002B11 M. De Marinis [Italie] ; F. Stocchi [Italie] ; B. Gregori [Italie] ; N. Accornero [Italie]Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failure
002B16 Georg Ebersbach [Allemagne] ; Martin Sojer [Autriche] ; Tjoerg Muller [Autriche] ; Michaela Heijmenberg [Allemagne] ; Werner Poewe [Autriche]Sociocultural differences in gait
002B31 R. J. Elble [États-Unis] ; K. Leffler [États-Unis]Pushing and pulling with the upper extremities while standing : The effects of mild Alzheimer dementia and Parkinson's disease
002B42 M. Hallett [États-Unis]Physiology of human posthypoxic myoclonus
002B62 J. Raethjen [Allemagne] ; M. Lindemann [Allemagne] ; H. Schmaljohann [Allemagne] ; R. Wenzelburger [Allemagne] ; G. Pfister [Allemagne] ; G. Deuschl [Allemagne]Multiple oscillators are causing parkinsonian and essential tremor
002B66 A. Curra [Italie] ; A. Berardelli [Italie] ; R. Agostino [Italie] ; M. Giovannelli [Italie] ; G. Koch [Italie] ; M. Manfredi [Italie]Movement cueing and motor execution in patients with dystonia : A kinematic study
002B68 E. B. Jr Montgomery [États-Unis] ; K. B. Baker [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Motor initiation and execution in essential tremor and Parkinson's disease
002B96 Anette Schrag [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]How does Parkinson's Disease affect quality of life? A comparison with quality of life in the general population
002C08 Hubert H. Fernandez [États-Unis] ; Kate L. Lapane [États-Unis]Estrogen use among nursing home residents with a diagnosis of Parkinson's disease
002C18 Deborah J. Serrien [Suisse] ; Jean-Marc Burgunder [Suisse] ; Mario Wiesendanger [Suisse]Disturbed sensorimotor processing during control of precision grip in patients with writer's cramp
002C19 R. Leiguarda [Argentine] ; M. Merello [Argentine] ; J. Balej [Argentine] ; S. Starkstein [Argentine] ; M. Nogues [Argentine] ; C. D. Marsden [Royaume-Uni]Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy
002C20 Lauri V. Laitinen [Suède] ; Darko Chudy [Croatie] ; Magnus Tengvar [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède]Dilated perivascular spaces in the putamen and pallidum in patients with Parkinson's disease scheduled for pallidotomy: A comparison between MRI findings and clinical symptoms and signs
002C22 John G. Nutt [États-Unis] ; Eric S. Lea ; Laura Van Houten ; Robert A. Schuff ; Gary J. SextonDeterminants of tapping speed in normal control subjects and subjects with Parkinson's disease : Differing effects of brief and continued practice
002C47 D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni]Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay
002C55 M. Michaud [Canada] ; A. Chabli [Canada] ; G. Lavigne [Canada] ; J. Montplaisir [Canada]Arm restlessness in patients with restless legs syndrome
002C75 A. Filla [Italie] ; G. De Michele [Italie] ; G. Coppola [Italie] ; A. Federico [Italie] ; G. Vita [Italie] ; A. Toscano [Italie] ; A. Uncini [Italie] ; P. Pisanelli [Italie] ; P. Barone [Italie] ; V. Scarano [Italie] ; A. Perretti [Italie] ; L. Santoro [Italie] ; A. Monticelli [Italie] ; F. Cavalcanti [Italie] ; G. Caruso [Italie] ; S. Cocozza [Italie]Accuracy of clinical diagnostic criteria for Friedreich's Ataxia
002C77 B. M. Ross [Canada] ; K. Eder [Allemagne] ; A. Moszczynska [Canada] ; N. Mamalias [Canada] ; J. Lamarche [Canada] ; LEE ANG [Canada] ; M. Pandolfo [Canada] ; G. Rouleau [Canada] ; M. Kirchgessner [Allemagne] ; S. J. Kish [Canada]Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1
002C93 M. Merello [Argentine] ; M. I. Nouzeilles [Argentine] ; G. Kuzis [Argentine] ; A. Cammarota [Argentine] ; L. Sabe [Argentine] ; O. Betti [Argentine] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine]Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum : A prospective randomized comparison
002D06 C. D. Hardman [Australie] ; G. M. Halliday [Australie]The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
002D32 A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges
002D33 C. G. Goetz [États-Unis]Rating scales for dyskinesias in Parkinson's disease
002D39 G. K. Wenning [Autriche] ; G. Ebersbach [Autriche] ; M. Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; A. Mckee [États-Unis] ; Werner Poewe [États-Unis] ; I. Litvan [États-Unis]Progression of falls in postmortem-confirmed Parkinsonian disorders
002D49 B. Barbiroli [Italie] ; P. Martinelli [Italie] ; A. Patuelli [Italie] ; R. Lodi [Italie] ; S. Iotti [Italie] ; P. Cortelli [Italie] ; P. Montagna [Italie]Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease
002D68 A. Brashear [États-Unis] ; G. K. Mulholland [États-Unis] ; Q.-H. Zheng [États-Unis] ; M. R. Farlow [États-Unis] ; E. R. Siemers [États-Unis] ; G. D. Hutchins [États-Unis]PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP)
002D71 T. Müller [Allemagne] ; H. Przuntek [Allemagne] ; W. Kuhn [Allemagne] ; S. S. Baum [Allemagne] ; H. Rommelspacher [Allemagne]No increase of synthesis of (R)salsolinol in Parkinson's disease
002D82 L. J. P. Defebvre [France] ; P. Derambure [France] ; J.-L. Bourriez [France] ; F. Cassim [France] ; J. D. Guieu [France] ; A. Destee [France]Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease : A spatiotemporal study of event-related desynchronization
002E08 L. D. Oliveira [Brésil] ; F. Cardoso [Brésil] ; A. P. Vargas [Brésil]Hemifacial spasm and arterial hypertension
002E24 Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients
002E38 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; E. Chiu [Australie] ; A. Tudor [Australie] ; L. O'Gorman [Australie] ; J. G. Phillips [Australie]Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
002E55 G. Northoff [Allemagne] ; A. Koch [Allemagne] ; J. Wenke [Allemagne] ; J. Eckert [Allemagne] ; H. Böker [Allemagne] ; B. Pflug [Allemagne] ; B. Bogerts [Allemagne]Catatonia as a psychomotor syndrome : A rating scale and extrapyramidal motor symptoms
002E72 C. G. Goetz [États-Unis] ; E. J. Pappert [États-Unis] ; E. D. Louis [États-Unis] ; R. Raman [États-Unis] ; S. Leurgans [États-Unis]Advantages of a modified scoring method for the rush video-based tic rating scale
002E85 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; H. Lee [États-Unis] ; H. Andrews [États-Unis]A comparison of different bedside tests for essential tremor
002F05 R. Lindeboom [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; M. Aramideh [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; R. J. De Haan [Pays-Bas]Treatment of cervical dystonia : A comparison of measures for outcome assessment
002F08 M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]The subthalamic nucleus and tremor in Parkinson's disease
002F11 J. C. Rothwell [Royaume-Uni] ; K. Higuchi [Japon] ; J. A. Obeso [Espagne]The offset cortical potential : An electrical correlate of movement inhibition in man
002F25 A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie]Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study
002F26 Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study
002F49 H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël]Physiology of MPTP tremor
002F57 E. J. Skalabrin [États-Unis] ; E. R. Jr Laws [États-Unis] ; J. P. Jr Bennett [États-Unis]Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease
002F66 C. H. Adler [États-Unis] ; K. A. Gwinn [États-Unis] ; S. Newman [États-Unis]Olfactory function in restless legs syndrome
002F67 N. Fabre [France] ; C. Brefel [France] ; U. Sabatini [Italie] ; P. Celsis [France] ; J. L. Montastruc [France] ; F. Chollet [France] ; Olivier Rascol [France]Normal frontal perfusion in patients with frozen gait
002F92 B. Holmberg [Suède] ; L. Rosengren [Suède] ; J.-E. Karlsson [Suède] ; B. Johnels [Suède]Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease
002F96 J. Montplaisir [Canada] ; S. Boucher [Canada] ; A. Nicolas [Canada] ; P. Lesperance [Canada] ; A. Gosselin [Canada] ; P. Rompre [Canada] ; G. LavigneImmobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome
003008 J. M. Hausdorff [États-Unis] ; M. E. Cudkowicz [États-Unis] ; R. Firtion [États-Unis] ; J. Y. Wei [États-Unis] ; A. L. Goldberger [États-Unis]Gait variability and basal ganglia disorders : Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease
003037 I. Delalande [France] ; J. C. Hache [France] ; G. Forzy [France] ; M. Bughin [France] ; J. Benhadjali [France] ; A. Destee [France]Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?
003044 R. K. B. Pearce [Royaume-Uni] ; T. Banerji ; P. Jenner ; C. D. MarsdenDe novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset
003055 A. Brashear [États-Unis] ; W. T. Ambrosius [États-Unis] ; G. J. Eckert [États-Unis] ; E. R. Siemers [États-Unis]Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
003056 D. Tarsy [États-Unis]Comparison of acute- and delayed-onset posttraumatic cervical dystonia
003062 E. S. Molho [États-Unis] ; P. J. Feustel [États-Unis] ; S. A. Factor [États-Unis]Clinical comparison of tardive and idiopathic cervical dystonia
003070 D. W. Anderson [États-Unis] ; W. A. Rocca [États-Unis] ; M. C. De Rijk [Pays-Bas] ; F. Grigoletto [Italie] ; M. O. Melcon [Argentine] ; M. B. Breteler [Pays-Bas] ; D. M. Maraganore [États-Unis]Case ascertainment uncertainties in prevalence surveys of Parkinson's disease
003111 A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
003158 G. Abbruzzese [Italie] ; R. Marchese [Italie] ; C. Trompetto [Italie]Sensory and motor evoked potentials in multiple system atrophy : A comparative study with Parkinson's disease
003159 A. Straube [Allemagne] ; J.-B. Mennicken [Allemagne] ; M. Riedel [Allemagne] ; T. Eggert [Allemagne] ; N. Müller [Allemagne]Saccades in Gilles de la Tourette's syndrome
003168 F. Federico [Italie] ; I. L. Simone [Italie] ; V. Lucivero [Italie] ; G. Iliceto [Italie] ; M. De Mari [Italie] ; P. Giannini [Italie] ; D. M. Mezzapesa [Italie] ; A. Tarantino [Italie] ; P. Lamberti [Italie]Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders
003198 G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine]Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon
003208 H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; I. Daum [Allemagne] ; G. Scharf [Allemagne] ; S. Spieker [Allemagne]Kinematic analysis of articulatory movements in central motor disorders
003215 N. Georgiou [Australie] ; J. G. Phillips [Australie] ; J. L. Bradshaw [Australie] ; R. Cunnington [Australie] ; E. Chiu [Australie]Impairments of movement kinematics in patients with Huntington's disease : A comparison with and without a concurrent task
003239 J. N. Joyce [États-Unis] ; G. Smutzer [États-Unis] ; C. J. Whitty [États-Unis] ; A. Myers [États-Unis] ; M. J. Bannon [États-Unis]Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease
003246 C. Sampaio [Portugal] ; J. J. Ferreira [Portugal] ; F. Simoes [Portugal] ; M. J. Rosas [Portugal] ; M. Magalhaes [Portugal] ; A. P. Correia [Portugal] ; A. Bastos-Lima [Portugal] ; R. Martins [Portugal] ; A. Castro-Caldas [Portugal]DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
003248 M. I. Nouzeilles [Argentine] ; M. Merello [Argentine]Correlation between results of motor section of UPDRS and Webster scale
003252 G. Becker [Allemagne] ; M. Naumann [Allemagne] ; M. Scheubeck [Allemagne] ; E. Hofmann [Allemagne] ; M. Deimling [Allemagne] ; A. Lindner [Allemagne] ; G. Gahn [Allemagne] ; C. Reiners [Allemagne] ; K. V. Toyka [Allemagne] ; K. Reiners [Allemagne]Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis
003253 B. T. Johnston [États-Unis] ; J. A. Castell [États-Unis] ; S. Stumacher [États-Unis] ; T. Colcher [États-Unis] ; R. M. Gideon [États-Unis] ; Q. Li [États-Unis] ; D. O. Castell [États-Unis]Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy
003254 R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; D. Mcguire [États-Unis] ; P. Silverstein [États-Unis] ; F. Zwiebel [États-Unis] ; M. Robischon [États-Unis] ; W. C. Koller [États-Unis]Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease : Pharmacokinetic and quality-of-life measures
003255 D. Tarsy [États-Unis]Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
003261 G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine]Clinical and pharmacological differences in early- versus late-onset Parkinson's disease
003267 Y. Nagahama [Japon] ; H. Fukuyama [Japon] ; N. Turjanski [Royaume-Uni] ; A. Kennedy [Royaume-Uni] ; H. Yamauchi [Japon] ; Y. Ouchi [Japon] ; J. Kimura [Japon] ; D. J. Brooks [Royaume-Uni] ; H. Shibasaki [Japon]Cerebral glucose metabolism in corticobasal degeneration : Comparison with progressive supranuclear palsy and normal controls
003330 R. J. Elble [États-Unis] ; M. Brilliant ; K. Leffler ; C. HigginsQuantification of essential tremor in writing and drawing
003336 R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis]Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study
003415 A. Benazzouz [France] ; T. Boraud [France] ; J. Feger [France] ; P. Burbaud [France] ; B. Bioulac [France] ; C. Gross [France]Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment
003443 F. Valldeoriola [Espagne] ; J. Valls-Sole ; E. S. Tolosa ; M. J. MartiStriated anal sphincter denervation in patients with progressive supranuclear palsy
003444 XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada]Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy
003515 V. Plante-Bordeneuve [Royaume-Uni] ; O. Bandmann ; G. Wenning ; N. P. Quinn ; S. E. Daniel ; A. E. HardingCYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
003525 R. Sprengelmeyer [Allemagne] ; A. G. M. Canavan ; H. W. Lange ; V. HömbergAssociative learning in degenerative neostriatal disorders : contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases
003534 Olivier Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France]Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
003542 N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
003588 G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. MoscarelliPergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
003614 L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. ChaseFluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
003643 W. Ashraf [États-Unis] ; R. F. Pfeiffer ; E. M. M. Quigley [États-Unis]Anorectal manometry in the assessment of anorectal function in parkinson's disease : a comparison with chronic idiopathic constipation
003772 H.-C. Diener [Allemagne] ; J. Dichgans ; B. Guschlbauer ; M. Bacher ; H. Rapp ; T. KlockgetherThe coordination of posture and voluntary movement in patients with cerebellar dysfunction
003855 E. Sasso ; E. Perucca ; R. Fava ; S. CalzettiQuantitative comparison of barbiturates in essential hand and head tremor
003892 Joseph Jankovic [États-Unis] ; L. StoneDystonic tics in patients with Tourette's syndrome
003917 D. Eidelberg ; J. R. Moeller ; V. Dhawan ; J. J. Sidtis ; J. Z. Ginos ; S. C. Strother ; J. Cedarbaum ; P. Greene ; S. Fahn ; D. A. RottenbergThe metabolic anatomy of Parkinson's disease : complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies
003923 S. A. Factor ; T. Mcalarney ; J. R. Sanchez-Ramos ; W. J. WeinerSleep disorders and sleep effect in Parkinson's disease
003941 J. N. Sanes ; M. HallettLimb positioning and magnitude of essential tremor and other pathological tremors
003970 K. Marder ; P. Flood ; L. Cote ; R. MayeuxA pilot study of risk factors for dementia in Parkinson's disease
003A03 R. M. Dubinsky ; M. Greenberg ; G. Di Chiro ; M. Baker ; M. HallettHemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose
003A09 Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander LindenComparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations
003A16 L. E. Adler ; M. Pecevich ; H. NagamotoBereitschaftspotential in tardive dyskinesia
003A58 S. Ruggieri ; F. Stocchi ; A. Carta ; D. Bravi ; M. Bragoni ; L. Giorgi ; A. AgnoliComparison between L-dopa and lisuride intravenous infusions: a clinical study
003A62 P. Greene ; H. Shale ; S. FahnAnalysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs
003A78 J. L. Montastruc ; P. Celsis ; A. Agniel ; J. F. Demonet ; B. Doyon ; M. Puel ; J. P. Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease: lack of correlation with clinical or neuropsychological improvements

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024